Animal ID
|
TTE
|
Acoustic Power (W)
|
Mean propagation path length, z (cm)
|
Derated Intensity, I
D
(kW/cm2)
|
Medulla norepinephrine (ng/mL/g)
|
Spinous process enhancement (mm)
|
---|
Left
|
Right
|
Ratio (R/L)
|
---|
11
|
9d
|
80
|
8.9
|
0.40
|
2322
|
1322
|
0.57
|
0
|
2
|
9d
|
80
|
8.6
|
0.41
|
1131
|
1480
|
1.31
|
0
|
9
|
6 m
|
80
|
7.5
|
0.62
|
1655
|
2440
|
1.47
|
0
|
12
|
9d
|
80
|
7.3
|
0.65
|
2402
|
1187
|
0.49
|
20
|
20
|
9d
|
80
|
7.2
|
0.67
|
1658
|
3239
|
1.95
|
0
|
18
|
9d
|
80
|
7.1
|
0.70
|
2248
|
1334
|
0.59
|
0
|
5
|
6 m
|
80
|
7.1
|
0.74
|
591
|
1241
|
2.10
|
0
|
17
|
9d
|
80
|
6.5
|
0.81
|
810
|
771
|
0.95
|
21
|
8
|
9d
|
200
|
9.5
|
0.90
|
992
|
1139
|
1.15
|
19
|
7
|
6 m
|
140
|
7.8
|
1.00
|
3048
|
2907
|
0.95
|
0
|
14
|
9d
|
140
|
7.7
|
1.04
|
484
|
789
|
1.63
|
18
|
1
|
9d
|
140
|
7.5
|
1.10
|
899
|
2572
|
2.86
|
9
|
21
|
9d
|
140
|
7.5
|
1.11
|
855
|
892
|
1.04
|
20
|
3
|
9d
|
200
|
8.0
|
1.19
|
992
|
2246
|
2.26
|
7
|
19
|
9d
|
140
|
7.0
|
1.31
|
4478
|
1350
|
0.30
|
28
|
4
|
6 m
|
140
|
6.9
|
1.33
|
229
|
29
|
0.12
|
19
|
15
|
9d
|
200
|
8.0
|
1.38
|
861
|
953
|
1.11
|
38
|
13
|
9d
|
200
|
7.7
|
1.49
|
1880
|
1216
|
0.65
|
20
|
6
|
6 m
|
200
|
7.3
|
1.49
|
646
|
295
|
0.46
|
0
|
16
|
9d
|
140
|
6.4
|
1.54
|
539
|
385
|
0.71
|
17
|
23
|
9d
|
140
|
6.3
|
1.54
|
1027
|
197
|
0.19
|
11
|
24
|
9d
|
200
|
7.6
|
1.59
|
1339
|
837
|
0.63
|
22
|
10
|
6 m
|
200
|
7.3
|
1.70
|
1065
|
1457
|
1.37
|
0
|
22
|
9d
|
200
|
7.2
|
1.78
|
653
|
311
|
0.48
|
27
|
- Spinous process enhancement measures the maximum length of any hyper intensity present around the right spinous process after the post-contrast 3D T1w VIBE images. The solid line separator indicates the animal treated with a low or high derated acoustic intensity (1.2 kW/cm2 threshold)